Literature DB >> 25194703

Expression of mediators of purinergic signaling in human liver cell lines.

Jessica R Goree1, Elise G Lavoie, Michel Fausther, Jonathan A Dranoff.   

Abstract

Purinergic signaling regulates a diverse and biologically relevant group of processes in the liver. However, progress of research into functions regulated by purinergic signals in the liver has been hampered by the complexity of systems probed. Specifically, there are multiple liver cell subpopulations relevant to hepatic functions, and many of these have been effectively modeled in human cell lines. Furthermore, there are more than 20 genes relevant to purinergic signaling, each of which has distinct functions. Hence, we felt the need to categorize genes relevant to purinergic signaling in the best characterized human cell line models of liver cell subpopulations. Therefore, we investigated the expression of adenosine receptor, P2X receptor, P2Y receptor, and ecto-nucleotidase genes via RT-PCR in the following cell lines: LX-2, hTERT, FH11, HepG2, Huh7, H69, and MzChA-1. We believe that our findings will provide an excellent resource to investigators seeking to define functions of purinergic signals in liver physiology and liver disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25194703      PMCID: PMC4272373          DOI: 10.1007/s11302-014-9425-4

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  58 in total

1.  Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors.

Authors:  Anatoliy I Masyuk; Sergio A Gradilone; Jesus M Banales; Bing Q Huang; Tatyana V Masyuk; Seung-Ok Lee; Patrick L Splinter; Angela J Stroope; Nicholas F Larusso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-07       Impact factor: 4.052

Review 2.  Impact of ectoenzymes on p2 and p1 receptor signaling.

Authors:  Filip Kukulski; Sébastien A Lévesque; Jean Sévigny
Journal:  Adv Pharmacol       Date:  2011

Review 3.  P2X receptors as drug targets.

Authors:  R Alan North; Michael F Jarvis
Journal:  Mol Pharmacol       Date:  2012-12-19       Impact factor: 4.436

4.  The GDA1_CD39 superfamily: NTPDases with diverse functions.

Authors:  Aileen F Knowles
Journal:  Purinergic Signal       Date:  2011-01-21       Impact factor: 3.765

5.  Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells.

Authors:  Ardeshir Z Hashmi; Wyel Hakim; Emma A Kruglov; Azuma Watanabe; William Watkins; Jonathan A Dranoff; Wajahat Z Mehal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10-19       Impact factor: 4.052

6.  Biliary adenocarcinoma. Characterisation of three new human tumor cell lines.

Authors:  A Knuth; H Gabbert; W Dippold; O Klein; W Sachsse; D Bitter-Suermann; W Prellwitz; K H Meyer zum Büschenfelde
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

Review 7.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

8.  ATP release after partial hepatectomy regulates liver regeneration in the rat.

Authors:  Emmanuel Gonzales; Boris Julien; Valérie Serrière-Lanneau; Alexandra Nicou; Isabelle Doignon; Laura Lagoudakis; Isabelle Garcin; Daniel Azoulay; Jean-Charles Duclos-Vallée; Denis Castaing; Didier Samuel; Andres Hernandez-Garcia; Samir S Awad; Laurent Combettes; Sundararajah Thevananther; Thierry Tordjmann
Journal:  J Hepatol       Date:  2009-10-24       Impact factor: 25.083

9.  Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.

Authors:  Guido Beldi; Yan Wu; Yara Banz; Michael Nowak; Lindsay Miller; Keiichi Enjyoji; Arvand Haschemi; Gennady G Yegutkin; Daniel Candinas; Mark Exley; Simon C Robson
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

Review 10.  Purinergic signalling in the liver in health and disease.

Authors:  Geoffrey Burnstock; Byron Vaughn; Simon C Robson
Journal:  Purinergic Signal       Date:  2013-11-24       Impact factor: 3.765

View more
  5 in total

1.  Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model.

Authors:  Miguel Á Manzanares; Akihiro Usui; Deanna J Campbell; Catherine I Dumur; Gabrielle T Maldonado; Michel Fausther; Jonathan A Dranoff; Alphonse E Sirica
Journal:  Am J Pathol       Date:  2017-03-15       Impact factor: 4.307

Review 2.  Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.

Authors:  Zhichao Zhou; Takayuki Matsumoto; Vera Jankowski; John Pernow; S Jamal Mustafa; Dirk J Duncker; Daphne Merkus
Journal:  Pharmacol Res       Date:  2018-12-13       Impact factor: 7.658

3.  The Cholangiocyte Adenosine-IL-6 Axis Regulates Survival During Biliary Cirrhosis.

Authors:  Elise G Lavoie; Michel Fausther; Jessica R Goree; Jonathan A Dranoff
Journal:  Gene Expr       Date:  2017-09-11

4.  P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients.

Authors:  Janielle P Maynard; Ju-Seog Lee; Bo Hwa Sohn; Xiaoying Yu; Dolores Lopez-Terrada; Milton J Finegold; John A Goss; Sundararajah Thevananther
Journal:  Oncotarget       Date:  2015-12-01

Review 5.  Ion Channels and Oxidative Stress as a Potential Link for the Diagnosis or Treatment of Liver Diseases.

Authors:  Ana Ramírez; Alma Yolanda Vázquez-Sánchez; Natalia Carrión-Robalino; Javier Camacho
Journal:  Oxid Med Cell Longev       Date:  2016-01-05       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.